Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. From Wikipedia
Fed minutes pointed to likely further rate cuts this year, bolstering confidence in growth leaders.
